Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $300.08 in the prior trading day, AMGEN Inc (NASDAQ: AMGN) closed at $284.67, down -5.14%. In other words, the price has decreased by -$5.14 from its previous closing price. On the day, 4.57 million shares were traded. AMGN stock price reached its highest trading level at $298.5 during the session, while it also had its lowest trading level at $281.66.
Ratios:
Our goal is to gain a better understanding of AMGN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.43. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 7.57 whereas as Long-Term Debt/Eq ratio is at 7.24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 05 ’25 when Khosla Rachna sold 1,500 shares for $289.68 per share. The transaction valued at 434,520 led to the insider holds 8,162 shares of the business.
Khosla Rachna bought 1,500 shares of AMGN for $435,000 on Jun 05 ’25. On May 02 ’25, another insider, Busch Matthew C., who serves as the VP, Finance & CAO of the company, sold 1,000 shares for $279.69 each. As a result, the insider received 279,690 and left with 4,034 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMGN now has a Market Capitalization of 161354956800 and an Enterprise Value of 201328459776. As of this moment, AMGEN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.29, and their Forward P/E ratio for the next fiscal year is 13.21. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.59. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.40 while its Price-to-Book (P/B) ratio in mrq is 20.63. Its current Enterprise Value per Revenue stands at 5.766 whereas that against EBITDA is 12.703.
Stock Price History:
The Beta on a monthly basis for AMGN is 0.48, which has changed by -0.12325603 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, AMGN has reached a high of $339.17, while it has fallen to a 52-week low of $253.30. The 50-Day Moving Average of the stock is -2.71%, while the 200-Day Moving Average is calculated to be -2.13%.
Shares Statistics:
The stock has traded on average 2.57M shares per day over the past 3-months and 2210730 shares per day over the last 10 days, according to various share statistics. A total of 538.30M shares are outstanding, with a floating share count of 536.60M. Insiders hold about 0.21% of the company’s shares, while institutions hold 81.12% stake in the company. Shares short for AMGN as of 1752537600 were 14702181 with a Short Ratio of 5.72, compared to 1749772800 on 13271690. Therefore, it implies a Short% of Shares Outstanding of 14702181 and a Short% of Float of 2.74.
Dividends & Splits
In the trailing 12 months, AMGN’s forward annual dividend rate was 4.5, compared to 9.26 this year. Against a Trailing Annual Dividend Yield of 0.0149960015The stock’s 5-year Average Dividend Yield is 3.03. The current Payout Ratio is 119.05% for AMGN, which recently paid a dividend on 2025-05-16 with an ex-dividend date of 2025-08-22. Stock splits for the company last occurred on 1999-11-22 when the company split stock in a 2:1 ratio.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 23.0 analysts currently analyzing and rating the stock of AMGEN Inc (AMGN).The consensus estimate for the next quarter is $5.23, with high estimates of $5.74 and low estimates of $4.83.
Analysts are recommending an EPS of between $21.62 and $20.43 for the fiscal current year, implying an average EPS of $20.97. EPS for the following year is $21.5, with 31.0 analysts recommending between $23.2 and $20.06.
Revenue Estimates
23 analysts predict $8.98B in revenue for the current quarter. It ranges from a high estimate of $9.22B to a low estimate of $8.77B. As of the current estimate, AMGEN Inc’s year-ago sales were $8.5BFor the next quarter, 23 analysts are estimating revenue of $9.35B. There is a high estimate of $9.66B for the next quarter, whereas the lowest estimate is $9.08B.
A total of 30 analysts have provided revenue estimates for AMGN’s current fiscal year. The highest revenue estimate was $36.32B, while the lowest revenue estimate was $34.92B, resulting in an average revenue estimate of $35.55B. In the same quarter a year ago, actual revenue was $33.42BBased on 30 analysts’ estimates, the company’s revenue will be $36.15B in the next fiscal year. The high estimate is $37.86B and the low estimate is $34.74B.
